$0.26
1.59% day before yesterday
Nasdaq, Nov 28, 10:13 pm CET
ISIN
US03828A1016
Symbol
APLT

Applied Therapeutics, Inc. Stock price

$0.26
-1.04 80.00% 1M
-0.12 31.05% 6M
-0.60 69.63% YTD
-8.31 96.97% 1Y
-0.64 71.16% 3Y
-22.90 98.88% 5Y
-9.14 97.23% 10Y
-9.14 97.23% 20Y
Nasdaq, Closing price Fri, Nov 28 2025
-0.00 1.59%
ISIN
US03828A1016
Symbol
APLT
Industry

Key metrics

Basic
Market capitalization
$37.5m
Enterprise Value
$7.1m
Net debt
positive
Cash
$30.4m
Shares outstanding
141.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
312.7 | 110.4
EV/Sales
59.2 | 20.9
EV/FCF
negative
P/B
2.2
Financial Health
Equity Ratio
65.8%
Return on Equity
-185.3%
ROCE
-569.9%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$120.0k | $340.0k
EBITDA
$-111.0m | $-96.3m
EBIT
$-111.6m | $-98.7m
Net Income
$-68.2m | $-82.9m
Free Cash Flow
$-91.3m
Growth (TTM | estimate)
Revenue
-98.8% | -26.1%
EBITDA
- | 7.3%
EBIT
7.8% | 5.4%
Net Income
72.0% | 21.5%
Free Cash Flow
-23.8%
Margin (TTM | estimate)
Gross
-
EBITDA
-90,989.3% | -28,317.3%
EBIT
-91,512.3%
Net
-55,859.0% | -24,378.4%
Free Cash Flow
-74,821.3%
More
EPS
$-0.5
FCF per Share
$-0.6
Short interest
8.5%
Employees
35
Rev per Employee
$10.0k
Show more

Is Applied Therapeutics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

Applied Therapeutics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Applied Therapeutics, Inc. forecast:

7x Buy
64%
4x Hold
36%

Analyst Opinions

11 Analysts have issued a Applied Therapeutics, Inc. forecast:

Buy
64%
Hold
36%

Financial data from Applied Therapeutics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
0.12 0.12
99% 99%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 67 67
48% 48%
55,992%
- Research and Development Expense 44 44
49% 49%
36,900%
-111 -111
-
-92,508%
- Depreciation and Amortization 0.64 0.64
-
533%
EBIT (Operating Income) EBIT -112 -112
8% 8%
-93,038%
Net Profit -68 -68
72% 72%
-56,792%

In millions USD.

Don't miss a Thing! We will send you all news about Applied Therapeutics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Applied Therapeutics, Inc. Stock News

Neutral
GlobeNewsWire
9 days ago
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today announced that Applied Therapeutics' Board of Directors (the “Board”) has initiated a process to explore strategic alternatives for the Company. The Board intends to evaluate a b...
Neutral
GlobeNewsWire
16 days ago
–   Update on regulatory strategy for govorestat for the treatment of CMT-SORD following receipt of Type C meeting minutes –   Meeting scheduled with the FDA in 4Q 2025 to discuss govorestat for the treatment of Classic Galactosemia –   New data on govorestat for the treatment of PMM2-CDG published in JIMD and presented at the 2025 ASHG Annual Meeting –   Announces Board of Directors Leadership...
Neutral
Business Wire
about one month ago
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Applied Therapeutics, Inc. (NASDAQ: APLT) breached their fiduciary duties to shareholders. If you currently own Applied stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-ap...
More Applied Therapeutics, Inc. News

Company Profile

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.

Head office United States
CEO Les Funtleyder
Employees 35
Founded 2016
Website www.appliedtherapeutics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today